We are leaders in drug discovery, cancer biology, functional genomics and translational medicine pursuing the bold goal of tackling the genetic complexity of cancer. We are focused on drivers of cancer not targeted by current drugs as we seek to address a large unmet need for people with cancer.
- Barbara Weber, MDChief Executive Officer
- Alan Huang, PhDChief Scientific Officer
- Daniella Beckman, CPAChief Financial Officer
- Charles Davis, PhDPharmaceutical Sciences
- Dimitris Papoutsakis, PhDOperations, Program and Portfolio Management
- Jeff Caravella, MBAFinance
- John Maxwell, PhDChemistry